Mandate

Vinge advises the Second Swedish National Pension Fund and the Sixth Swedish National Pension Fund and their portfolio company Norrporten AB (publ) in relation to an exit process

April 15, 2016

Vinge advises the Second Swedish National Pension Fund and the Sixth Swedish National Pension Fund and their portfolio company Norrporten AB (publ) in relation to the exit process entailing a sale of Norrporten to a private buyer or an IPO and listing of shares in Norrporten on Nasdaq Stockholm.

The exit process resulted in a sale of Norrporten to Castellum AB (publ), listed on Nasdaq Stockholm, at a price of SEK 14.0 billion, based on an issue price in Castellum’s issue in kind of SEK 133 per share and including a dividend of SEK 464 million. Castellum will at closing pay SEK 10.4 billion in cash and 23.41 million Castellum shares to the AP-funds. Prior to the sale, Norrporten had been approved for listing on Nasdaq Stockholm by Nasdaq Stockholm’s listing committee.
 
Norrporten is one of Sweden’s largest office property companies with centrally located properties in Swedish urban growth centres and in Copenhagen. As of 31 December 2015, Norrporten’s property portfolio across eleven geographical market areas comprised 120 properties with a total leasable area of more than 1,140,000 square metres and an aggregate property value of SEK 25.8 billion.
 
Vinge’s team primarily consisted of Charlotte Levin, Fredrik Sonander, Joakim Hagberg, Erik Claesson, Nils Fredrik Dehlin and Joel Wahlberg. Maria Schultzberg, Emilie Parland, Ulf Käll and Victor Ericsson assisted in tax related matters, Albert Wållgren and Linn Adelwald assisted in financing related matters, Anna Palmérus and Karin Wisénius in competition law related matters and Åsa Gotthardsson assisted in employment law related matters.

Related

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.
January 22, 2025

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.
January 20, 2025